FENC Competitors & Alternatives
Compare Fennec Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
FENC
Main Stock$10.75
Tradestie Score
61
Market Cap
$266.91M
Revenue Growth
0.7%
Analyst Upside
+45.7%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.86
|
$386.68M | - | 64 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.00
|
$382.04M | - | 53 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.18
|
$371.64M | - | 63 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$20.61
|
$357.51M | - | 44 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.87
|
$354.45M | - | 61 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$32.25
|
$353.70M | - | 63 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.61
|
$350.98M | - | 55 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.99
|
$341.56M | - | 62 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.63
|
$332.96M | - | 60 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.94
|
$328.62M | - | 57 | Compare |
More FENC Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry